SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Mark A. Stang who wrote (11106)7/10/1998 8:00:00 AM
From: DaiS  Read Replies (2) | Respond to of 23519
 
>>>
I am considering going long again, but I don't see how VVUS will be able to continue R&D based upon its current cash position and cash flow, so the gene therapy and incontinence products seem pretty worthless in terms of adding any value to the company now. >>>

Don't bite my head off, but if these innovations have promise could not Vivus borrow a bit against them like these ED companies that have no products?

DaiS